Literature DB >> 10727891

Induction of mucosal immune responses in the human genital tract.

J Mestecky1, M W Russell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10727891     DOI： 10.1111/j.1574-695X.2000.tb01449.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN： 0928-8244


× No keyword cloud information.
  16 in total

1.  A new murine model for testing vaccines against genital Chlamydia trachomatis infections in males.

Authors:  Sukumar Pal; Annahita K Sarcon; Luis M de la Maza
Journal:  Vaccine       Date:  2010-10-13       Impact factor: 3.641

2.  Local Probiotic Therapy for Vaginal Candida albicans Infections.

Authors:  Stefan Miladinov Kovachev; Rossitza Stefanova Vatcheva-Dobrevska
Journal:  Probiotics Antimicrob Proteins       Date:  2015-03       Impact factor: 4.609

3.  Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization.

Authors:  Pooja Ralli-Jain; Delia Tifrea; Chunmei Cheng; Sukumar Pal; Luis M de la Maza
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

Review 4.  Identification and characterization of gonococcal iron transport systems as potential vaccine antigens.

Authors:  C N Cornelissen
Journal:  Future Microbiol       Date:  2008-06       Impact factor: 3.165

5.  Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model.

Authors:  Chunmei Cheng; Sukumar Pal; Ilham Bettahi; Kristie L Oxford; Peter A Barry; Luis M de la Maza
Journal:  Vaccine       Date:  2011-03-04       Impact factor: 3.641

Review 6.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

7.  Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17beta-estradiol-treated mice.

Authors:  Wenxia Song; Sara Condron; Brian T Mocca; Sandra J Veit; Dawn Hill; Asima Abbas; Ann E Jerse
Journal:  Vaccine       Date:  2008-08-30       Impact factor: 3.641

8.  Engineering Vaccines for Tissue-Resident Memory T Cells.

Authors:  Frances C Knight; John T Wilson
Journal:  Adv Ther (Weinh)       Date:  2021-01-20

9.  Transferrin conjugation confers mucosal molecular targeting to a model HIV-1 trimeric gp140 vaccine antigen.

Authors:  J F S Mann; D Stieh; K Klein; D S Miranda de Stegmann; M P Cranage; R J Shattock; P F McKay
Journal:  J Control Release       Date:  2011-11-15       Impact factor: 9.776

10.  Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations.

Authors:  Aditya Pattani; Paul F McKay; Martin J Garland; Rhonda M Curran; Katarzyna Migalska; Corona M Cassidy; R Karl Malcolm; Robin J Shattock; Helen O McCarthy; Ryan F Donnelly
Journal:  J Control Release       Date:  2012-08-07       Impact factor: 9.776
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.